Shanghai Able Digital Science&Tech Co., Ltd. — Board/Management Information 2024

Dec 19, 2024

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

中信资源控股有限公司

CITIC Resources Holdings Limited

(Incorporated in Bermuda with limited liability)

(Stock Code: 1205)

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF RISK MANAGEMENT COMMITTEE

The board (the "Board") of directors (the "Directors", and each a "Director") of CITIC Resources Holdings Limited (the "Company") announces that, with effect from 5:00 p.m. on 19 December 2024, Dr. Jin Cai ("Dr. Cai") has been appointed to the following positions:

(1) independent non-executive Director; and
(2) member of the risk management committee of the Company.

The biographical details of Dr. Cai are set out below:

Dr. Cai Jin, aged 43, is a neo-institutionalist economist and private investor who holds a Doctoral degree (Ph.D.) in Economics from the Chinese Academy of Social Sciences (under the joint supervision of the Institute of World Economics and Politics and the Asia-Pacific Research Institute), with a focus on the History of Money in the domain of International Political Economy. Dr. Cai also holds an MBA from the Conservatoire National des Arts et Métiers, a Master's degree in Law with a specialization in Legal History from Renmin University of China, and a Bachelor's degree in Economics specializing in Finance and Banking from Xiamen University.

---

Dr. Cai has a solid academic background and extensive leadership experience in international cooperation and major projects. Dr. Cai has previously held positions in Poly Technologies, Inc., a subsidiary of the stated-owned enterprise, China Poly Group Corporation, between 2012 and 2016, with her last position being Deputy General Manager where she was responsible for strategic development, international trading and legal matters. She previously worked in the Department of International Cooperations at China South Industries Group between 2004 and 2008, where she was responsible for managing contract negotiations and joint venture projects. She also practiced law as a founding partner at HanTong Law Firm between 2008 and 2009.

In March 2023, Dr. Cai was appointed Vice-chairman of the Investment Association of China, and in July 2023, she was named the Asia Chair of Gate Center, a think tank in the Spanish-speaking regions. In January 2024, she took a role as Chief Strategy Officer (CSO) for AXA Group in Greater China. Dr. Cai was also a member of the first cohort of France-China Young Leaders pursuant to the "Young Leader" program organized by the France China Foundation.

The Company and Dr. Cai have entered into a letter of appointment in respect of the appointment of Dr. Cai as an independent non-executive Director. Dr. Cai has no fixed term of service with the Company but is subject to retirement and re-election at the next general meeting of the Company after her appointment becomes effective and, thereafter, to retirement by rotation and re-election at annual general meetings in accordance with the bye-laws of the Company.

Dr. Cai will be entitled to receive a director's fee of HK$400,000 per annum and a fee for being a member of a Board committee of HK$30,000 per annum. The fees are determined on the same basis as those paid by the Company to other independent non-executive Directors and Board committee members.

As at the date hereof, Dr. Cai does not hold any interest in the shares of the Company within the meaning of Part XV of the SFO.

Dr. Cai has confirmed that, save as disclosed above, (i) she has no other relationships with any Directors, senior management or substantial or controlling shareholders of the Company; (ii) she does not currently hold any other position with the Company or any of its subsidiaries; (iii) she has not held any directorship in any other Hong Kong or overseas listed public companies in the last three years; and (iv) there are no other matters relating to the aforesaid appointment that need to be brought to the attention of holders of securities of the Company, nor are there other information relating to the aforesaid appointment to be disclosed pursuant to any of the requirements of Rule 13.51(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

2

---

Dr. Cai has further confirmed with the Company (i) her independence as regards each of the factors referred to in Rule 3.13(1) to (8) of the Listing Rules; (ii) that she has no past or present financial or other interest in the business of the Company or its subsidiaries or any connection with any core connected person (as defined in the Listing Rules) of the Company; and (iii) that there are no other factors that may affect Dr. Cai’s independence at the time of her appointment.

By Order of the Board of
CITIC Resources Holdings Limited
Hao Weibao
Chairman

Hong Kong, 19 December 2024

As at the date hereof, Mr. Hao Weibao and Mr. Wang Xinli are executive directors of the Company; Mr. Chan Kin is a non-executive director of the Company; and Dr. Fan Ren Da, Anthony, Mr. Look Andrew, Mr. Lu Dequan and Dr. Cai Jin are independent non-executive directors of the Company.

3